tiprankstipranks
Trending News
More News >
Swedish Orphan Biovitrum Ab (SE:SOBI)
:SOBI
Sweden Market

Swedish Orphan Biovitrum AB (SOBI) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

SOBI Analyst Ratings

Strong Buy
5Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Swedish
Orphan Biovitrum AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SOBI Stock 12 Month Forecast

Average Price Target

kr363.00
▲(18.16%Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Swedish Orphan Biovitrum AB in the last 3 months. The average price target is kr363.00 with a high forecast of kr380.00 and a low forecast of kr350.00. The average price target represents a 18.16% change from the last price of kr307.20.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"277":"kr277","303":"kr303","329":"kr329","355":"kr355","381":"kr381"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":380,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">kr380.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":363,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">kr363.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":350,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">kr350.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[277,303,329,355,381],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,293,299.6923076923077,306.38461538461536,313.0769230769231,319.7692307692308,326.46153846153845,333.15384615384613,339.84615384615387,346.53846153846155,353.2307692307692,359.9230769230769,366.61538461538464,373.3076923076923,{"y":380,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,293,298.38461538461536,303.7692307692308,309.15384615384613,314.53846153846155,319.9230769230769,325.3076923076923,330.6923076923077,336.0769230769231,341.46153846153845,346.84615384615387,352.2307692307692,357.61538461538464,{"y":363,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,293,297.38461538461536,301.7692307692308,306.15384615384613,310.53846153846155,314.9230769230769,319.3076923076923,323.6923076923077,328.0769230769231,332.46153846153845,336.84615384615387,341.2307692307692,345.61538461538464,{"y":350,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":285.4,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":282.4,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":285.8,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":278,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":315.8,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":309,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":329.4,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":305.4,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":317.4,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":335.8,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":315.6,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":285.6,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":293,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Targetkr380.00Average Price Targetkr363.00Lowest Price Targetkr350.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on SE:SOBI
TipRanks AITipRanks
Not Ranked
TipRanks
kr342
Buy
11.33%
Upside
Reiterated
06/03/25
Swedish Orphan Biovitrum AB's stock score is primarily supported by its solid financial performance, reflecting efficient management and robust profitability. Technical analysis shows mild bullish momentum, although mixed longer-term trends. The valuation suggests a fairly priced stock with growth potential, though lacking a dividend yield for immediate income. The absence of earnings call and corporate event data limits additional insights.
Barclays Analyst forecast on SE:SOBI
Shirley ChenBarclays
Barclays
kr380kr350
Buy
13.93%
Upside
Reiterated
05/09/25
Swedish Orphan Bio (SOBI:SS) (SWTUY) PT Lowered to SEK350 at BarclaysBarclays analyst Shirley Chen lowered the price target on Swedish Orphan Bio (SOBI:SS) (OTC: SWTUY) to SEK350.00 (from SEK380.00) while maintaining a Overweight rating.
Kepler Capital  Analyst forecast on SE:SOBI
Jon BerggrenKepler Capital
Kepler Capital
kr360kr350
Buy
13.93%
Upside
Upgraded
04/30/25
Kepler Cheuvreux Upgrades Swedish Orphan Bio (SOBI:SS) (SWTUY) to BuyKepler Cheuvreux analyst Jon Berggren upgraded Swedish Orphan Bio (SOBI:SS) (OTC: SWTUY) from Hold to Buy with a price target of SEK350.00 (from SEK360.00).
RBC Capital
kr380
Buy
23.70%
Upside
Reiterated
04/30/25
Swedish Orphan Biovitrum AB (0MTD) Receives a Buy from RBC Capital
Berenberg Bank Analyst forecast on SE:SOBI
Harry GillisBerenberg Bank
Berenberg Bank
kr360kr370
Buy
20.44%
Upside
Reiterated
04/30/25
Swedish Orphan Bio (SOBI:SS) (SWTUY) PT Raised to SEK370 at BerenbergBerenberg analyst Harry Gillis raised the price target on Swedish Orphan Bio (SOBI:SS) (OTC: SWTUY) to SEK370.00 (from SEK360.00) while maintaining a Buy rating.
DNB Markets Analyst forecast on SE:SOBI
Patrik LingDNB Markets
DNB Markets
kr365
Buy
18.82%
Upside
Reiterated
04/03/25
DNB Markets Reiterates Buy Rating on Swedish Orphan Bio (SOBI:SS) (SWTUY)DNB Markets analyst Patrik Ling reiterated a Buy rating and SEK365.00 price target on Swedish Orphan Bio (SOBI:SS) (OTC: SWTUY).
Deutsche Bank  Analyst forecast on SE:SOBI
Emmanuel PapadakisDeutsche Bank
Deutsche Bank
kr275kr285
Sell
-7.23%
Downside
Reiterated
02/13/25
Swedish Orphan Bio (SOBI:SS) (SWTUY) PT Raised to SEK285 at Deutsche BankDeutsche Bank analyst Emmanuel Papadakis raised the price target on Swedish Orphan Bio (SOBI:SS) (OTC: SWTUY) to SEK285.00 (from SEK275.00) while maintaining a Sell rating.
Jefferies Analyst forecast on SE:SOBI
Brian BalchinJefferies
Jefferies
kr310kr308
Hold
0.26%
Upside
Reiterated
01/07/25
Swedish Orphan Bio (SOBI:SS) (SWTUY) PT Lowered to SEK308 at JefferiesJefferies analyst Brian Balchin lowered the price target on Swedish Orphan Bio (SOBI:SS) (OTC: SWTUY) to SEK308.00 (from SEK310.00) while maintaining a Hold rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on SE:SOBI
TipRanks AITipRanks
Not Ranked
TipRanks
kr342
Buy
11.33%
Upside
Reiterated
06/03/25
Swedish Orphan Biovitrum AB's stock score is primarily supported by its solid financial performance, reflecting efficient management and robust profitability. Technical analysis shows mild bullish momentum, although mixed longer-term trends. The valuation suggests a fairly priced stock with growth potential, though lacking a dividend yield for immediate income. The absence of earnings call and corporate event data limits additional insights.
Barclays Analyst forecast on SE:SOBI
Shirley ChenBarclays
Barclays
kr380kr350
Buy
13.93%
Upside
Reiterated
05/09/25
Swedish Orphan Bio (SOBI:SS) (SWTUY) PT Lowered to SEK350 at BarclaysBarclays analyst Shirley Chen lowered the price target on Swedish Orphan Bio (SOBI:SS) (OTC: SWTUY) to SEK350.00 (from SEK380.00) while maintaining a Overweight rating.
Kepler Capital  Analyst forecast on SE:SOBI
Jon BerggrenKepler Capital
Kepler Capital
kr360kr350
Buy
13.93%
Upside
Upgraded
04/30/25
Kepler Cheuvreux Upgrades Swedish Orphan Bio (SOBI:SS) (SWTUY) to BuyKepler Cheuvreux analyst Jon Berggren upgraded Swedish Orphan Bio (SOBI:SS) (OTC: SWTUY) from Hold to Buy with a price target of SEK350.00 (from SEK360.00).
RBC Capital
kr380
Buy
23.70%
Upside
Reiterated
04/30/25
Swedish Orphan Biovitrum AB (0MTD) Receives a Buy from RBC Capital
Berenberg Bank Analyst forecast on SE:SOBI
Harry GillisBerenberg Bank
Berenberg Bank
kr360kr370
Buy
20.44%
Upside
Reiterated
04/30/25
Swedish Orphan Bio (SOBI:SS) (SWTUY) PT Raised to SEK370 at BerenbergBerenberg analyst Harry Gillis raised the price target on Swedish Orphan Bio (SOBI:SS) (OTC: SWTUY) to SEK370.00 (from SEK360.00) while maintaining a Buy rating.
DNB Markets Analyst forecast on SE:SOBI
Patrik LingDNB Markets
DNB Markets
kr365
Buy
18.82%
Upside
Reiterated
04/03/25
DNB Markets Reiterates Buy Rating on Swedish Orphan Bio (SOBI:SS) (SWTUY)DNB Markets analyst Patrik Ling reiterated a Buy rating and SEK365.00 price target on Swedish Orphan Bio (SOBI:SS) (OTC: SWTUY).
Deutsche Bank  Analyst forecast on SE:SOBI
Emmanuel PapadakisDeutsche Bank
Deutsche Bank
kr275kr285
Sell
-7.23%
Downside
Reiterated
02/13/25
Swedish Orphan Bio (SOBI:SS) (SWTUY) PT Raised to SEK285 at Deutsche BankDeutsche Bank analyst Emmanuel Papadakis raised the price target on Swedish Orphan Bio (SOBI:SS) (OTC: SWTUY) to SEK285.00 (from SEK275.00) while maintaining a Sell rating.
Jefferies Analyst forecast on SE:SOBI
Brian BalchinJefferies
Jefferies
kr310kr308
Hold
0.26%
Upside
Reiterated
01/07/25
Swedish Orphan Bio (SOBI:SS) (SWTUY) PT Lowered to SEK308 at JefferiesJefferies analyst Brian Balchin lowered the price target on Swedish Orphan Bio (SOBI:SS) (OTC: SWTUY) to SEK308.00 (from SEK310.00) while maintaining a Hold rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Swedish Orphan Biovitrum AB

1 Month
xxx
Success Rate
8/11 ratings generated profit
73%
Average Return
+3.53%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 72.73% of your transactions generating a profit, with an average return of +3.53% per trade.
3 Months
xxx
Success Rate
11/17 ratings generated profit
65%
Average Return
+1.08%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of +1.08% per trade.
1 Year
Emmanuel PapadakisDeutsche Bank
Success Rate
8/11 ratings generated profit
73%
Average Return
+9.99%
reiterated a sell rating 4 months ago
Copying Emmanuel Papadakis's trades and holding each position for 1 Year would result in 72.73% of your transactions generating a profit, with an average return of +9.99% per trade.
2 Years
xxx
Success Rate
9/11 ratings generated profit
82%
Average Return
+20.21%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 81.82% of your transactions generating a profit, with an average return of +20.21% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SOBI Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
0
0
0
0
0
Buy
6
7
6
8
7
Hold
2
4
3
2
0
Sell
0
1
1
1
0
Strong Sell
0
0
0
0
0
total
8
12
10
11
7
In the current month, SOBI has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SOBI average Analyst price target in the past 3 months is 363.00.
Each month's total comprises the sum of three months' worth of ratings.

SOBI Financial Forecast

SOBI Earnings Forecast

Next quarter’s earnings estimate for SOBI is kr1.57 with a range of kr1.52 to kr1.67. The previous quarter’s EPS was kr2.55. SOBI beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year SOBI has Outperformed its overall industry.
Next quarter’s earnings estimate for SOBI is kr1.57 with a range of kr1.52 to kr1.67. The previous quarter’s EPS was kr2.55. SOBI beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year SOBI has Outperformed its overall industry.

SOBI Sales Forecast

Next quarter’s sales forecast for SOBI is kr6.27B with a range of kr6.03B to kr6.71B. The previous quarter’s sales results were kr6.46B. SOBI beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year SOBI has Outperformed its overall industry.
Next quarter’s sales forecast for SOBI is kr6.27B with a range of kr6.03B to kr6.71B. The previous quarter’s sales results were kr6.46B. SOBI beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year SOBI has Outperformed its overall industry.

SOBI Stock Forecast FAQ

What is SE:SOBI’s average 12-month price target, according to analysts?
Based on analyst ratings, Swedish Orphan Biovitrum Ab’s 12-month average price target is 363.00.
    What is SE:SOBI’s upside potential, based on the analysts’ average price target?
    Swedish Orphan Biovitrum Ab has 18.16% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Swedish Orphan Biovitrum Ab a Buy, Sell or Hold?
          Swedish Orphan Biovitrum Ab has a consensus rating of Strong Buy, which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Swedish Orphan Biovitrum Ab’s share price target?
            The average share price target for Swedish Orphan Biovitrum Ab is 363.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is kr380.00 ,and the lowest forecast is kr350.00. The average share price target represents 18.16% Increase from the current price of kr307.2.
              What do analysts say about Swedish Orphan Biovitrum Ab?
              Swedish Orphan Biovitrum Ab’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of Swedish Orphan Biovitrum Ab?
                To buy shares of SE:SOBI, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis